ArticleAmerican journal of translational research2020

The inhibition of BRAF activity sensitizes chemoresistant human ovarian cancer cells to paclitaxel-induced cytotoxicity and tumor growth inhibition.

Ling Zhao et al.PubMed ↗Full text ↗

No numbers read from the abstract.